SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Omeros
An SI Board Since March 2010
Posts SubjectMarks Bans Symbol
464 28 0 OMER
Emcee:  Bradpalm1 Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
39VERY significant news IMO ...... eurekalert.org <b>Simple injection coulHoward Williams-4/18/2011
38Oh man and I'd broken into the top ten on the biotech contest too! Bradpalm,Steve Lokness-3/31/2011
37Omeros making a great run lately. In addition to this news the OMS103HP data is Bradpalm1-3/25/2011
36Omeros' Ophthalmology Product OMS302 Achieves Co-Primary Endpoints in Phase Howard Williams-3/23/2011
35prnewswire.com Omeros Unlocks Orphan GPCRs Linked to Pancreatic Cancer and CognHoward Williams-3/2/2011
34Omeros Announces Expansion of Exclusive License to PDE7 Inhibitors from Daiichi Howard Williams-2/22/2011
33This was the con call info: pitchengine.comshaneaj-2/10/2011
32nationalsecurities.com Just his Bio...shaneaj-2/10/2011
31shaneaj; Your link is incomplete and I don't see it on OMER web site. Any chSteve Lokness-2/10/2011
30Just listened in on call hosted by Jason Kolbert of National Securities (http://shaneaj-2/10/2011
29Omeros Announces Eligibility of OMS103HP for EMA Centralized Marketing ApplicatiHoward Williams-2/1/2011
28Thanks Howard. I believe several other positive developments are in the works foBradpalm1-1/6/2011
27<i> PT $10. </i> Needham really stepping out on the limb here sinceSteve Lokness-1/6/2011
26Needham & Company reiterates a 'Buy' on Omeros Corp. (NASDAQ: OMER),Howard Williams-1/6/2011
25Omeros Licenses Novel Antifibrinolytic Agents prnewswire.com -- IND-Enabling Howard Williams-1/5/2011
24Omeros Announces Positive Clinical Results of OMS201 in Patients Undergoing UretHoward Williams-12/29/2010
23A positive article on Omeros from a reporter who hadn't always been so encouBradpalm1112/14/2010
22There's some saying about "great minds", but I forgot what it was.Bradpalm1-12/6/2010
21Well TM, this makes at least two companies we share an interest in, the other onHoward Williams-12/6/2010
20Mark my words this stock will trade strongly into 2011. Just 25yrs experience trTheMaster-12/3/2010
19This market only reacts when a company does "The Triple Gainer" off thTheMaster-11/30/2010
18Nov. 23, 2010, 7:00 a.m. EST Omeros Announces Completion of Acquisition of AssHoward Williams-11/23/2010
17OMEROS : Identifies Orphan GPCR-Targeting Compound Potentiating ChemotherapeuticHoward Williams-11/9/2010
16Omeros Corporation Awarded $1.7 Million in Grants Under the Qualifying TherapeutHoward Williams-11/3/2010
15Here is wording from LSDF that I was wondering about, especially the second boldSteve Lokness-10/26/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News